Friday, November 6, 2020
- 9:00AM-11:00AM
-
Abstract Number: 0389
Organ Specific Treatment Patterns of a Real-World, Electronic Health Record Cohort of Patients with Systemic Sclerosis
Systemic Sclerosis & Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 0122
Osteoporosis Medication Utilization Patterns over Time in the ACR RISE Registry
Osteoporosis & Metabolic Bone Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 0321
Outcome Measures in Psoriatic Arthritis Registries Are Very Heterogeneous: A Systematic Literature Review of 27 Registries, or 16183 Patients
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 0400
Outcomes of Systemic Sclerosis Hospitalizations by Hospital Teaching Status: Analysis of the National Inpatient Sample
Systemic Sclerosis & Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 0284
Oxidative DNA Damage Accelerates Skin Inflammation in Pristane-induced Lupus Model
SLE – Etiology & Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 0318
Oxylipin Profile Is Associated with Skin Disease and Enthesitis in Psoriatic Disease
Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes Poster I: Psoriatic Arthritis- 9:00AM-11:00AM
-
Abstract Number: 0028
Pain in the Time of Corona: Impact of COVID 19 Outbreak on Fibromyalgia Patients
Fibromyalgia & Other Clinical Pain Syndromes Poster- 9:00AM-11:00AM
-
Abstract Number: 0275
Paradoxical Relationship Between Disease Activity and Satisfaction with Care in Lupus
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations- 9:00AM-11:00AM
-
Abstract Number: 0256
Patient Perspective of the Type 1 and 2 SLE Model: A Qualitative Study
SLE – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Manifestations- 9:00AM-11:00AM
-
Abstract Number: 0159
Patient-Reported Data Show the Impact of Time to Diagnosis in RA
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA- 9:00AM-11:00AM
-
Abstract Number: 0169
Patient-Reported Outcomes Differentiate Between Remission and Low Disease Activity in Psoriatic Arthritis
Patient Outcomes, Preferences, & Attitudes Poster I: RA, Spondyloarthritis, & OA- 9:00AM-11:00AM
-
Abstract Number: 0011
Patients Receiving Cytokine Inhibitors Have Low Prevalence of SARS-CoV-2 Infection
Epidemiology & Public Health Poster I: COVID-19 & Rheumatic Disease- 9:00AM-11:00AM
-
Abstract Number: 0193
Patients with Asthma Have a Higher Risk of Rheumatoid Arthritis: A Systematic Review and Meta-analysis
RA – Diagnosis, Manifestations, & Outcomes Poster I: Multimorbidity